What does 20/20 Biolabs, Inc. do?

20/20 Biolabs, Inc. is a public company in the Services-Testing Laboratories industry, incorporated in DE. It is registered with the SEC under CIK 0001139685 and trades on NASDAQ under the ticker AIDX.

What is 20/20 Biolabs, Inc.'s annual revenue?

20/20 Biolabs, Inc. reported $2.05M in revenue for fiscal year 2025, according to its 10-K filing with the SEC.

Is 20/20 Biolabs, Inc. profitable?

20/20 Biolabs, Inc. reported a net loss of $3.74M in FY2025. This figure is sourced from its SEC EDGAR 10-K annual report.

How many SEC filings has 20/20 Biolabs, Inc. made?

20/20 Biolabs, Inc. has filed 128 documents with the SEC since 2002. These include annual reports (10-K), quarterly reports (10-Q), current event notices (8-K), and insider transaction disclosures (Form 4).

20/20 Biolabs, Inc.

AIDX NASDAQ CIK: 0001139685 Services-Testing Laboratories Inc. in DE

View on SEC.gov →

Overview All Filings Annual Quarterly Insiders

Recent Filings

All 128 filings →

Form	Description	Date
SCHEDULE 13G	—	Mar 10, 2026
SCHEDULE 13D	—	Mar 10, 2026
4	—	Mar 4, 2026
SCHEDULE 13G	—	Feb 25, 2026
4	—	Feb 23, 2026
4	—	Feb 23, 2026
4	—	Feb 23, 2026
4	—	Feb 23, 2026
3	—	Feb 23, 2026
3	—	Feb 19, 2026

Insider Transactions

View all →

No insider transactions loaded yet.

About This Profile

This page aggregates all publicly available SEC EDGAR data for 20/20 Biolabs, Inc.. Financial figures are sourced from XBRL-tagged 10-K annual reports. Insider transactions are sourced from Form 4 filings required within two business days of a transaction.

Key Financials

Revenue: $2.05M (FY2025)
Net Income: ($3.74M) (FY2025)
Total Assets: $4.14M (FY2025)
Operating Income: ($3.33M)

Full financials →

Details

CIK: 0001139685
Ticker: AIDX
Exchange: NASDAQ
Incorporated: DE
First Filing: 2002
Total Filings: 128

Services-Testing Laboratories rankings →